The reduced expression (haplodeficiency) of the main brain derived neurotrophic factor receptor, namely TrkB is associated with reduced atherosclerosis, smooth muscle cells accumulation and collagen content in the lesion. These data support the concept that brain derived neurotrophic factor of vascular origin may contribute to atherosclerosis. However, to date, no experimental approach was possible to investigate this issue due to the lethality of brain derived neurotrophic factor null mice. To overcome these limitations, we generated a mouse model with a conditional deletion of brain derived neurotrophic factor in endothelial cells (Tie-2 Cre recombinase) on an atherosclerotic prone background (apolipoprotein E knock out) and investigated the effect of conditional brain derived neurotrophic factor deficiency on atherosclerosis. Despite brain derived neurotrophic factor reduction in the vascular wall, mice with conditional deletion of brain derived neurotrophic factor did not develop larger atherosclerotic lesion compared to controls. Smooth muscle cell content as well as the distribution of total and fibrillar collagen was similar in the atherosclerotic lesions from mice with brain derived neurotrophic factor conditional deficiency compared to controls. Finally an extended gene expression analysis failed to identify pro-atherogenic gene expression patterns among the animal with brain derived neurotrophic factor deficiency. In spite of the reduced brain derived neurotrophic factor expression, similar atherosclerosis development was observed in the brain derived neurotrophic factor conditional deficient mouse compared to controls. These pieces of evidence indicate that endothelial derivedbrain derived neurotrophic factor is not a pro-atherogenic factor and would rather suggest to investigate the role of other TrkB activators on atherosclerosis.
Introduction
The growth factor/receptor system of the brain derived neurotrophic factor (BDNF) and its receptor, the TrkB receptor, has been proposed as a critical player of lesion development during atherogenesis [1] . BDNF expression was observed in human and mouse atherosclerotic plaques mainly in extracellular matrix area [1] [2] [3] . Alteration of BDNF plasma levels in acute coronary syndromes was reported although the issue is controversial [3] [4] [5] .
Previous studies demonstrated that BDNF gene targeted mice exhibit vascular hemorrhage and early postnatal lethality [6] and that BDNF is critical for perinatal vessel stabilization through the activation of TrkB receptors [7] . Furthermore TrkB reduced expression (haplodeficiency) is associated with reduced atherosclerosis, smooth muscle cell accumulation and collagen content in the lesion [1] . While these observations suggest that TrkB receptor contributes to the development of atherosclerotic lesions through the modulation of smooth muscle cell function, the role of BDNF still remains elusive. Indeed, the key demonstration that BDNF deficiency is associated with increased atherosclerosis is lacking due to the impaired survival of BDNF null mice [6] . The origin of vascular BDNF is debated as platelet BDNF does not appear to be acquired from the megakaryocytes or the pituitary gland but from other sources via the blood circulation [8] . Endothelial cells can be a source of the neurotrophin [9] and also a target of BDNF/TrkB-mediated angiogenesis [10] . Also cells of hematological origin such as activated T cells, B cells and monocytes have been shown to produce BDNF in vitro and in vivo, at least in the brain [11] . Finally to a minor extent, passage through the brain blood barrier occurs [8] . These data suggest the possibility that BDNF of endothelial and/or hematopoietic origin could play a role in chronic inflammatory processes of the arterial wall such as atherosclerosis. To test this hypothesis, we generated a conditioned mouse model where, BDNF expression is selectively deleted in Tie2-CRE expressing cells on the background of apolipoprotein E knock out mice. Tie2 mediated Cre-recombinase expression has been extensively characterized and efficiently mediates recombination in endothelial cells and also in some hematopoietic cell in appropriate reporter mice [12] [13] [14] . Therefore, we evaluated atherosclerotic aortic lesion morphology and vascular gene expression patterns in Tie2-CRE; BDNFfloxed/floxed;ApoE Knock out mice (which are deficient in BDNF in the endothelium) compared to BDNFfloxed/floxed;ApoE Knock-out mice or Tie2-CRE;ApoE Knock out mice. The investigation conforms to the European Commission Directive 86/609/EEC and was approved by the local ethical committee (Progetto di Ricerca 2009/3). At 8 weeks of age, animals were fed ad libitum with western type diet (21% fat, 0.15% cholesterol and 19.5% casein, Harlan, Bresso, Italy) for 16 weeks. Mice were sacrificed with an overdose of Avertin 2.5% (Aldrich Chemical Co.USA), followed by cervical dislocation. The heart and the arterial tree were perfused with saline solution under physiological pressure. Then the aortas and the hearts were isolated and paraffin embedded [15] , while the aorta (from the last part of the ascending up to the thoracic aorta) was placed in a storing solution (RNA laterICEtm, Ambion, Germany) at −20°C or ad used for confirming through Q-PCR data from the cDNA microarray analysis. For RNA isolation the samples were homogenized in a dismembrator (Qiagen, Milan, Italy) then processed as described [16] .
Material and methods

Plasma lipid analysis and quantification of atherosclerosis
Blood samples were collected in EDTA tubes immediately before death by retro-orbital bleeding and plasma was separated by lowspeed centrifugation at 4°C. The measurement of plasma lipids was performed by standard enzymatic techniques (ABX for Cobas Mira Plus, Montpellier, France) [17] . Cross sequential sections 5 μm thick were prepared from the aortic root up to 150 μm after the valve leaflets were no longer detectable. For the aortic sinus and the ascending aorta the slides were stained with hematoxylin-eosin, for each tract of the aorta 15 sections were analyzed. Images of the aortas were captured with Axiovert 200 microscope and the atherosclerotic lesion area was quantified by computer image analysis, using Axiovision LE rel 4.4 software by two blinded observers as described [17] . The quantification of the collagen content was performed following picro-sirius red staining, images of the aortas were captured with Axiovert 200 microscope (ZEISS, Milan, Italy) under regular and polarized light, then fibrillar collagen, detected by yellow birefringence, was quantified using Image J analysis software, capable of color segmentation and automation by programmable macros, by two blinded observers. Data are expressed as the percentage of the total atherosclerotic lesion area covered by fibrillar collagen ± standard error.
cDNA microarray analysis
A comprehensive gene expression analysis was performed in the tract of the aorta between the aortic sinus and the ascending aorta where the morphometric analysis was performed as described [17] and is summarized in the Supplementary material section. The cDNA microarray experiments were performed according to the Minimum Information About a Microarray Experiment (MIAME) guidelines [18] , the raw data for each hybridization and the final processed files are accessible at the following address: http://www.sisalombardia.it/dati4/ dati4.htm. RNA was extracted from the aorta using the kit RNAeasy Formalin-fixed, paraffin-embedded (FFPE) tissue sections from Qiagen (Milan, Italy). The quality of the RNA was tested with standard procedures. Five hundred micrograms of RNA were then used for RNA amplification using the SuperScript RNA Amplification System (Invitrogen, Italy) according to the manufacturer's instructions. Two micrograms of amplified RNA was then processed for microarray experiments while the remaining was used for validation with Q-PCR as described below. For microarray experiments Dual Chip Mouse Inflammation microarray was used (Eppendorf, Italy). Biotin 11-dATP and biotin 11-cCTP cDNA were synthesized according to the protocol from the manufacturer and hybridized to the microarrays. For these experiments the gene expression pattern in male and female was investigated separately. The arrays were developed with the Silverquant Detection Kit (Eppendorf, Italy), the images were acquired with the Silverquant Detection Software and analyzed with the Silverquant Analysis Software (Eppendorf, Italy). Data are expressed as fold of induction of Tie2-CRE; BDNFfloxed/floxed;ApoE Knock out or BDNFfloxed/floxed;ApoE Knock out vs Tie2-CRE;ApoE Knock out. For each group, four replicates, each resulting from pooling the mRNA of three animals were analyzed.
Real time quantitative polymerase chain reaction
Total RNA was reverse transcribed as described [19, 20] . Three microliters of cDNA were amplified by real-time quantitative PCR with 1× Syber green universal PCR mastermix (BioRad, Italy). The specificity of the Syber green fluorescence was tested as described [19] . The primers used have been described previously [15] . Each sample was analyzed in duplicate using the IQTM-Cycler (BioRad). The PCR amplification was related to a standard curve ranging from 10-11 mol/L to 10-14 mol/L and data were normalized for the housekeeping gene ribosomal protein L13a (RLP13a) (NM_009438).
Immunohistochemistry
For macrophage, smooth muscle cell and T-lymphocyte detection, rat anti mouse F4/80 (antigen, AbD Serotec, Oxford, UK, dilution 1:100), rabbit polyclonal to CD3 and rabbit polyclonal to smooth muscle actin (Abcam, Cambridge UK, dilution 1:50 and 1:100 respectively), or non-immune IgG as a control was used (4°C overnight) followed by incubation with a secondary biotinylated antibody (anti-rabbit IgG or anti-rat IgG, Vector Laboratories, Burlingame, CA, USA, diluted 1:200 in 1% normal goat serum and PBS) for 1 h at room temperature. Immunoreactivity was visualized using avidin-biotin-peroxidase method (Vectastain ABC kit from Vector Laboratories, Burlingame, CA, USA) with 3,3′-diaminobenzidine substrate (Sigma, Italy) as the chromogen. Dehydrated sections were observed using Zeiss Axioskop microscope (Zeiss) and analyzed with color-video image analysis system linked to the microscope; for the quantification of the immunoreactive area the Image J analysis software, capable of color deconvolution and segmentation by programmable macros, was used.
Statistics
Data were analyzed using SPSS 16.0 for Windows (SPSS, Chicago, IL) with two way ANOVA followed by Scheffe contrast. When histological data were compared between groups, parametric t-tests setting the significance level at p b 0.05 were used and to compensate for a potential lack of normal distribution, nonparametric Wilcoxon tests were applied.
Results
Characterization of Tie2-CRE;BDNFfloxed/floxed;ApoE Knock out mice
Preliminary experiments showed no difference on atherosclerosis burden in Tie2-CRE;ApoE Knock out or BDNFfloxed/floxed;ApoE Knock out compared to ApoE knock out animals (data not shown); therefore in all experiments Tie2-CRE;BDNFfloxed/floxed;ApoE Knock out mice were compared to Tie2-CRE;ApoE Knock out and BDNFfloxed/floxed;ApoE Knock out mice. We first investigated Cre-recombinase expression which was selectively observed at the endothelial level ( Fig. 1 ) in agreement with previous findings [13] . In Tie2-CRE;BDNFfloxed/floxed;ApoE Knock out mice, BDNF mRNA levels were reduced in the aorta compared to Tie2-CRE;ApoE Knock out and BDNFfloxed/floxed;ApoE Knock out (from approximately 9000 to 300 mRNA copies relative to 10 5 copies of the housekeeping gene); on the contrary the expression of endothelial nitric oxide (eNOS), was not altered (Fig. 1 ). The analysis of BDNF and eNOS expression in mRNA from blood cells showed no differences among the animals of the different genotypes (data not shown), thus excluding the potential impact of Tie-2 mediated deletion in hematopoietic cells. These findings support the hypothesis that endothelial-derived BDNF significantly contributes to BDNF expression in the vascular wall. BDNF staining in the vessel of Tie2-CRE;BDNFfloxed/floxed; ApoE Knock out mice was reduced mainly in the sub-endothelial space compared to Tie2-CRE;ApoE Knock out and BDNFfloxed/ floxed;ApoE Knock out; the expression of TRK-B, although low and diffused, was not affected (Supplementary Figure I) . When plasma, serum levels or tissue levels of BDNF were analyzed with ELISA or western blotting, no detectable levels were recorded (data not shown), in agreement with previous papers suggesting that the detection of BDNF protein levels in mice is, up to date, technically limited [21, 22] .
Quantitative morphometry of atherosclerosis in Tie2-CRE;
BDNFfloxed/floxed;ApoE Knock out mice
After feeding the animals for 16 weeks with western type diet, no significant differences were observed in body weight or plasma lipid levels ( Table 1 ). Overall female developed larger atherosclerotic lesions as compared to male mice (Table 1) which is in agreement with previous observations [17, 23] .
Atherosclerotic lesion area in the aortic sinus was not significantly different among Tie2-CRE;BDNFfloxed/floxed;ApoE Knock out mice and Tie2-CRE;ApoE Knock out or BDNFfloxed/floxed;ApoE Knock out mice (Table 1 and Fig. 2 ). This was true even when in a subgroup of animals (four per group, two male and two female) atherosclerotic lesion area was measured throughout the first 200 μm of the aorta starting from the cuspids (Figure III, Supplementary material) . Finally, no atherosclerotic lesions were detected in the thoracic and abdominal aorta in each group (Figure II, Supplementary material) . Atherosclerosis development was also assessed in animals fed the atherogenic diet for 8 weeks or 36 weeks. Even at an early or at a later time point, atherosclerotic lesion area in the aortic sinus was not significantly different among Tie2-CRE;BDNFfloxed/floxed;ApoE Knock out mice or BDNFfloxed/floxed;ApoE Knock out mice ( Figure  IV, Supplementary material) .
Atherosclerotic plaque characterization in Tie2-CRE;BDNFfloxed/ floxed;ApoE Knock out mice
As haplodeficient expression of TRK-B is associated with altered cell accumulation in the atherosclerotic lesions [1] , we investigated the presence of smooth muscle cells (SMC) (Fig. 3B ,G,L), of macrophages ( Fig. 3E , J, O) and of T lymphocytes (Fig. 3C ,H,M) in the atherosclerotic plaque from Tie2-CRE;BDNFfloxed/floxed;ApoE knock out mice ( Fig. 3 panels A to E), from Tie2-CRE;ApoE Knock out ( Fig. 3 panels F to J) and from BDNFfloxed/floxed;ApoE Knock out mice ( Fig. 3 panels K to O) fed for 16 weeks with the western type diet. Although several smooth muscle cells, macrophages and, a limited amount of T-lymphocytes, were detected in the atherosclerotic plaques, no major differences among the animal groups were observed (SMC: 22.5 ± 7.8% for Tie2-CRE;BDNFfloxed/floxed;ApoE knock out mice vs 20.4 ± 6.5% for Tie2-CRE;ApoE Knock out and 25.9 ± 8.1%; macrophages: 9.3 ± 7.1%, 13.5 ± 4.8% and 15.6 ± 3.2% respectively; T cells: 4.2 ± 3.2%, 5.5 ± 2.7% and 7.2 ± 5.6% respectively). To further confirm these observations, mRNA was extracted from formalin-fixed-paraffin embedded slides next to those stained and a comprehensive gene expression analysis of specific markers of the cells present during the development of atherosclerosis in the vascular wall was performed as described by Veillard et al. [24] . Similar levels of mRNA for CD68 (a marker of monocyte/macrophages) and of mRNA for CD4 (a T-helper lymphocytes (Th) marker) were observed within the vascular wall of the aortic arch of the three groups of animals (Fig. 3P ). In addition the expression of mRNA for TIM3 probe (T-cell immunoglobulin domain, mucin domain), a marker of Th1 cells, or of chemokine receptor CCR4, a marker highly expressed in Th2 and regulatory T lymphocytes cells [24] was not different within the vascular wall of the aortic arch of the three groups of animals ( Fig. 3P ). Finally also the mRNA expression of α-actin, a marker of smooth muscle cells, resulted similar in all mice groups (Fig. 3P ). While these data suggest that Tie-2 conditional deletion of BDNF is not associated with increased atherosclerosis, they do not exclude the possibility that BDNF selective deficiency would be associated with altered vascular gene expression patterns. We therefore used a mouse inflammation focussed cDNA microarray to investigate the mRNA expression on the tract between the aortic sinus and the ascending aorta in mice fed for 16 weeks with western type diet (Fig. 4) . When data were analyzed using either Tie2-CRE;ApoE Knock out or BDNFfloxed/floxed;ApoE Knock out as reference group, among the genes present in the array, only a minor number appeared to be modulated in Tie2-CRE;BDNFfloxed/floxed;ApoE knock out mice. Furthermore, genes that resulted up or downregulated vs the Tie2-CRE;ApoE Knock out group were not modulated when data were compared vs the BDNFfloxed/floxed;ApoE Knock out group. To gain further insight into genes potentially involved in atherogenesis, the mRNA expression of adhesion molecules such as ICAM-1, VCAM-1 and of cytokines/chemokines such as MCP-1, IL-6 and IL10 was evaluated by Q-PCR (Fig. 3Q ). Again no relevant differences were observed among the three groups which support the lack of any relevant effect of endothelial BDNF deficiency on vascular inflammatory processes.
This does not exclude the possibility that despite similar SMC presence, those could differently affect plaque stability through the synthesis of collagen [25] ; we therefore investigated the mRNA expression of the main collagen isoforms and the collagen distribution in the vascular wall ( Fig. 5 ). No significant differences were observed in total collagen or fibrillar collagen distribution in the aortic sinus, furthermore mRNA expression of collagen 1A1, collagen 1A2 and collagen 3A1 was not significantly different between groups. Altogether these findings suggest that endothelial deficiency of BDNF is not associated with reduced atherosclerosis.
Discussion
BDNF plays a key role as an endothelial survival factor and supports angiogenesis through the activation of TrkB receptors [6, 10, 26] . TrkB reduced expression (haplodeficiency) is associated with a limited but significant reduction in atherosclerosis, smooth muscle cell accumulation and collagen content in the lesion [1] . Those data support the possibility that BDNF of vascular origin may contribute to atherosclerosis. However, to date, no experimental approach was possible to investigate this issue due to the lethality of BDNF null mice. To overcome this limitation, we generated an atherosclerotic prone mouse model with a conditional deletion of BDNF in endothelial cells which efficiently results in a reduction of BDNF expression in the vascular wall. Unexpectedly mice with endothelial conditional deletion of BDNF did not develop larger atherosclerotic lesion compared to controls. Furthermore, the presence of smooth muscle cells is similar in mice with BDNF conditional deletion and controls as it is the distribution of total collagen or fibrillar collagen in the atherosclerotic lesions in spite of data in TrkB haplodeficient mice where a reduced smooth muscle cell accumulation [1] was observed. Finally an extended gene expression analysis failed to identify altered inflammatory gene expression patterns in mice with BDNF conditional deficiency compared to controls.
As TrkB haplodeficiency has been demonstrated to protect against atherosclerosis in mice, our data would imply that TrkB engagement by factors other than endothelial-derived BDNF could be involved in smooth muscle cell accumulation and atherosclerosis. More importantly, in addition to other neurotrophins such as NT-4, spectra of TrkB activators are emerging [27] , including ephrin-A5 or lowdensity lipoprotein receptor-related protein 1 (LRP-1). NT4 [26] , ephrin-A5 [28] and LRP-1 [29] appear to be key players in the modulation of cell recruitment, survival or apoptosis in the cardiovascular system thus supporting the possibility also of BDNF-independent, TrkB-mediated effects in atherogenesis.
In summary, the generation of a Tie-2 Cre recombinase conditional mouse model on a pro-atherogenic background, allowed to overcome 
BDNF null mouse lethality and investigate the role of endothelial BDNF deficiency on atherogenesis. BDNF conditional deficient mouse did not developed smaller atherosclerotic lesions compared to controls. Future studies should investigate whether local overexpression of BDNF would affect the development of atherosclerosis or whether BDNF deficiency could result in atheroprotection in ApoE KO animals fed a chow diet. The role of BDNF in cardiovascular disease in humans is debated [3, 4] , and a strong involvement in angiogenesis was proposed [10, 26] . Furthermore, a series of pharmacological approaches aimed at modulating the BDNF/TrkB axis is under investigation not only for neurological disorders [30] but also for vascular disorders associated to dementia and as well as BDNF-mediated angiogenesis [31, 32] . Therefore, the data presented in this paper, which limit the impact of endothelial derived BDNF as a pro-atherogenic factor, support further investigations of BDNF mimetics in vascular disorders.
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